Best Pharmaceutical Stocks To Follow Now – May 10th

Eli Lilly and Company, D-Wave Quantum, AbbVie, McKesson, and Gilead Sciences are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are equity shares in publicly traded companies engaged in the research, development, manufacturing and marketing of prescription drugs and medical therapies. They offer investors potential growth tied to successful clinical trials and new drug approvals, but also carry risks from regulatory hurdles, patent expirations and competitive pressures. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

LLY traded down $15.24 during trading on Friday, reaching $736.21. 4,068,043 shares of the company’s stock were exchanged, compared to its average volume of 3,511,825. The company’s fifty day moving average price is $810.98 and its 200-day moving average price is $811.52. The company has a debt-to-equity ratio of 2.00, a quick ratio of 0.97 and a current ratio of 1.15. The firm has a market capitalization of $697.73 billion, a PE ratio of 62.87, a P/E/G ratio of 1.40 and a beta of 0.48. Eli Lilly and Company has a fifty-two week low of $677.09 and a fifty-two week high of $972.53.

D-Wave Quantum (QBTS)

D-Wave Quantum Inc. develops and delivers quantum computing systems, software, and services worldwide. The company offers Advantage, a fifth-generation quantum computer; Ocean, a suite of open-source python tools; and Leap, a cloud-based service that provides real-time access to a live quantum computer, as well as access to Advantage, hybrid solvers, the Ocean software development kit, live code, demos, learning resources, and a vibrant developer community.

Shares of NYSE:QBTS traded up $0.68 during midday trading on Friday, hitting $11.10. The company had a trading volume of 161,356,804 shares, compared to its average volume of 36,482,745. D-Wave Quantum has a 12 month low of $0.75 and a 12 month high of $11.95. The firm has a fifty day simple moving average of $7.41 and a 200 day simple moving average of $5.78. The stock has a market cap of $3.23 billion, a price-to-earnings ratio of -26.43 and a beta of 0.90.

AbbVie (ABBV)

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

NYSE:ABBV traded down $1.28 during mid-day trading on Friday, hitting $184.30. The company had a trading volume of 7,806,084 shares, compared to its average volume of 6,122,857. The firm has a market cap of $326.02 billion, a P/E ratio of 76.79, a P/E/G ratio of 1.62 and a beta of 0.56. AbbVie has a fifty-two week low of $153.58 and a fifty-two week high of $218.66. The business’s fifty day moving average is $194.23 and its two-hundred day moving average is $187.23. The company has a debt-to-equity ratio of 17.94, a quick ratio of 0.55 and a current ratio of 0.66.

McKesson (MCK)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

Shares of MCK stock traded up $3.87 on Friday, reaching $694.12. The company had a trading volume of 2,028,420 shares, compared to its average volume of 898,192. The company has a 50-day moving average of $678.24 and a 200-day moving average of $620.09. McKesson has a 12 month low of $464.42 and a 12 month high of $728.48. The stock has a market cap of $86.99 billion, a PE ratio of 31.78, a PEG ratio of 1.29 and a beta of 0.53.

Gilead Sciences (GILD)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.

NASDAQ:GILD traded down $1.30 during trading hours on Friday, hitting $96.86. The stock had a trading volume of 13,140,489 shares, compared to its average volume of 7,599,780. The business’s 50 day moving average is $107.23 and its 200-day moving average is $99.23. The company has a debt-to-equity ratio of 1.24, a quick ratio of 1.20 and a current ratio of 1.50. The company has a market cap of $120.61 billion, a price-to-earnings ratio of 261.78, a P/E/G ratio of 0.71 and a beta of 0.26. Gilead Sciences has a one year low of $62.07 and a one year high of $119.96.